Can One Molecule Treat Osteoarthritis and Rheumatoid Arthritis?

Can One Molecule Treat Osteoarthritis and Rheumatoid Arthritis?

In this episode of Arthritis Now, we talk with two-time ANRF grant recipient, Chuanju Liu, Ph.D. of NYU School of Medicine, about his work and whether one molecule can treat osteoarthritis and rheumatoid arthritis. Specifically we talk with him about his research on the progranulin molecule. Research that ANRF funded and that has lead him to also receive multiple grants from the National Institute of Health (NIH).

Currently there are no medications that treat the underlying causes of both osteoarthritis and rheumatoid arthritis. Osteoarthritis and rheumatoid arthritis are historically managed very differently because of the nature of them. Osteoarthritis usually appears after an injury or from wear and tear on bones, while rheumatoid arthritis is an autoimmune disease where your body’s own immune system attacks healthy tissue.

Dr. Liu explains progranulin’s function in the body, its connection to the better-known TNF molecule, and how his lab has been working with it to create a more broad-acting treatment for osteoarthritis and rheumatoid arthritis in the near future.

Watch Can One Molecule Treat Osteoarthritis and Rheumatoid Arthritis? above!

ANRF
Article Author
Arthritis National Research Foundation
arthritisresearch@curearthritis.org

The Arthritis National Research Foundation's mission is to provide initial research funding to brilliant, investigative scientists with new ideas to cure arthritis and related autoimmune diseases. Writing articles about the patients affected and the science being done to find a cure shows why we need to come together to #CureArthritis!

No Comments

Post A Comment